Phosphorus

WASHINGTON — Data presented here from the Dialysis Outcomes Practice Patterns Study indicated that patients who ate during their in-center hemodialysis treatments had higher serum albumin, higher potassium and lower phosphorus levels compared to patients who dialyzed at other clinics and did not eat during treatments.

WASHINGTON — Use of the sucroferric oxyhydroxide binder by Fresenius Medical Care Renal Therapies Group, Velphoro, was effective in lowering serum phosphorus levels for patients in their first year of hemodialysis therapy, according to results presented here.